The Beauty Health Company reported exceptional second-quarter results with a 371.2% increase in net sales compared to Q2 2020, driven by strong performance in both Delivery Systems and Consumables. The company is raising its full-year sales guidance to $230 million to $240 million.
Net sales increased by 371.2% to $66.5 million compared to Q2 2020.
Delivery System net sales increased to $34.9 million, while Consumables net sales increased to $31.6 million.
Gross margin increased to 71.0% compared to 30.3% in Q2 2020.
Adjusted EBITDA was $11.4 million, compared to an adjusted EBITDA loss of $1.1 million in Q2 2020.
BeautyHealth is raising its fiscal 2021 net sales guidance to $230 million to $240 million and expects adjusted EBITDA of approximately $25 million.
Visualization of income flow from segment revenue to net income